資產檔案
Lakewood-Amedex Biotherapeutics Inc is a clinical-stage biotechnology company developing a novel class of fast-acting, broad-spectrum antimicrobials - the Bisphosphocin class - to treat infectious diseases and reduce the threat posed by antibiotic-resistant ba…
最新在前。
Lakewood-Amedex 在 IDWeek 2026 發表 Nu-3 資料
同一家公司在本板塊內追蹤的其他藥物和在研候選。